Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.

Biotechnology

Amber Bio

Jacob Borrajo

Max Semler

Kamyab Javanmardi

Patty Biezonski

This department focuses on the design and development of biological systems and structures.

Bioarchitecture

This department focuses on advancing scientific knowledge and developing innovative solutions in various fields, particularly through machine learning and other technologies.

Research and Development

This department oversees organizational governance and strategic direction.

Governance Council

This department focuses on designing and innovating biological structures and systems.

Bioarchitecture Division

This department focuses on overseeing the development and management of the platform's capabilities and functions.

Development and Platform

This department oversees strategic development initiatives and manages the overall direction of growth projects.

Amber Bio

Org chart

Teams

Bioarchitecture

Research and Development

Governance Council

Bioarchitecture Division

Development and Platform

Development Leadership

Offices

Amber Bio

Org chart

Teams

Bioarchitecture

Research and Development

Governance Council

Bioarchitecture Division

Development and Platform

Development Leadership

Offices

Related companies